share_log

LAVA Medtech Acquisition Corp. (NASDAQ:LVAC) Short Interest Up 18.2% in September

Defense World ·  Oct 3, 2022 04:21

LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating) was the target of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 1,300 shares, a growth of 18.2% from the August 31st total of 1,100 shares. Based on an average daily volume of 18,200 shares, the short-interest ratio is currently 0.1 days.

Institutional Trading of LAVA Medtech Acquisition

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Starboard Value LP bought a new stake in LAVA Medtech Acquisition during the fourth quarter valued at $474,000. Saba Capital Management L.P. bought a new stake in LAVA Medtech Acquisition during the fourth quarter valued at $5,329,000. Oaktree Capital Management LP bought a new stake in LAVA Medtech Acquisition during the fourth quarter valued at $2,500,000. Beryl Capital Management LLC bought a new stake in LAVA Medtech Acquisition during the fourth quarter valued at $9,890,000. Finally, Toronto Dominion Bank bought a new position in shares of LAVA Medtech Acquisition during the 1st quarter worth about $2,994,000. 65.98% of the stock is currently owned by institutional investors and hedge funds.

Get LAVA Medtech Acquisition alerts:

LAVA Medtech Acquisition Stock Performance

NASDAQ LVAC opened at $10.03 on Monday. LAVA Medtech Acquisition has a twelve month low of $9.83 and a twelve month high of $10.07. The stock has a fifty day simple moving average of $10.03 and a 200 day simple moving average of $10.00.

LAVA Medtech Acquisition Company Profile

(Get Rating)

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries.

See Also

  • Get a free copy of the StockNews.com research report on LAVA Medtech Acquisition (LVAC)
  • Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
  • Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
  • Magna International is Your Auto and EV One-Stop Shop Stock
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30

Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment